|
|
|
|
LEADER |
00000cam a2200000 4500 |
001 |
1616020652 |
003 |
DE-627 |
005 |
20220606102518.0 |
007 |
tu |
008 |
930901s1992 xx ||||| 00| ||eng c |
020 |
|
|
|a 0160383951
|9 0-16-038395-1
|
024 |
8 |
|
|a SCNAC-102-1-10
|q Sonstige Nr.
|
035 |
|
|
|a (DE-627)1616020652
|
035 |
|
|
|a (DE-576)034950664
|
035 |
|
|
|a (DE-599)BSZ034950664
|
035 |
|
|
|a (OCoLC)26226104
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Study mission to Syria, Pakistan, Israel, and Italy
|b August 3 - 13, 1991; report of the Select Committee on Narcotics Abuse and Control, House of Representatives, 102. Congress, 1. session
|
264 |
|
1 |
|a Washington, DC
|b US Gov.Print.Off.
|c 1992
|
300 |
|
|
|a III, 52 S.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
0 |
|
|a Committee print / ... Congress ... session, House of Representatives
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
710 |
2 |
|
|a USA
|b Congress
|b House of Representatives
|b Select Committee on Narcotics Abuse and Control
|0 (DE-588)1048583-1
|0 (DE-627)100142443
|0 (DE-576)191429007
|4 oth
|
951 |
|
|
|a BO
|
ELC |
|
|
|b 1
|
LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
LOK |
|
|
|0 001 3196803260
|
LOK |
|
|
|0 003 DE-627
|
LOK |
|
|
|0 004 1616020652
|
LOK |
|
|
|0 005 20150903110722
|
LOK |
|
|
|0 008 930901||||||||||||||||ger|||||||
|
LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
LOK |
|
|
|0 852
|a DE-21
|
LOK |
|
|
|0 852 1
|c KB 8 E 4241
|9 00
|
LOK |
|
|
|0 935
|a sued
|a vord
|a krim
|
LOK |
|
|
|0 936ln
|a v11.3
|
LOK |
|
|
|0 936ln
|a v4.7
|
LOK |
|
|
|0 936ln
|a s7
|
ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
SIG |
|
|
|a UB: KB 8 E 4241
|